Search

Your search keyword '"Samaha, Hady"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Samaha, Hady" Remove constraint Author: "Samaha, Hady" Language english Remove constraint Language: english
23 results on '"Samaha, Hady"'

Search Results

1. Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study

2. Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

4. Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients

5. Persistent SARS-CoV-2–specific immune defects in kidney transplant recipients following third mRNA vaccine dose

6. Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study

7. Durability of immune responses to mRNA booster vaccination against COVID-19

8. Burden of Vaccine-Preventable Diseases in People Living with HIV.

9. AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans.

10. Efficacy and Durability of Immune Response after Receipt of HPV Vaccines in People Living with HIV.

11. SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses

12. mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

14. Calcification of the ascending aorta, left heart valves and coronaries: associated diseases and a new classification.

17. Heterologous versus homologous boosting elicits qualitatively distinct, BA.5-cross-reactive T cells in transplant recipients.

18. Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial.

20. Durability of immune responses to the booster mRNA vaccination against COVID-19.

21. mRNA bivalent booster enhances neutralization against BA.2.75.2 and BQ.1.1.

22. SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses.

23. mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant.

Catalog

Books, media, physical & digital resources